State Of Wyoming Adc Therapeutics Sa Transaction History

State Of Wyoming

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$2.55 - $5.09 $15,863 - $31,664	6,221 New	6,221 $19,000
Q2 2022 Aug 15, 2022	SELL	$5.96 - $14.99 $17,176 - $43,201	-2,882 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$13.28 - $20.03 $14,036 - $21,171	1,057 Added 57.92%	2,882 $42,000
Q4 2021 Feb 11, 2022	BUY	$19.29 - $31.51 $5,324 - $8,696	276 Added 17.82%	1,825 $37,000
Q3 2021 Feb 11, 2022	SELL	$20.45 - $30.0 $16,503 - $24,210	-807 Reduced 34.25%	1,549 $42,000
Q2 2021 Feb 11, 2022	BUY	$20.38 - $27.04 $30,182 - $40,046	1,481 Added 169.26%	2,356 $57,000
Q1 2021 Feb 08, 2022	BUY	$22.75 - $34.05 $19,906 - $29,793	875 New	875 $21,000

55M

82.7K

31.5K

Ticker ADCT
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,645,296
Market Cap $186M
Description
ADC Therapeutics SA, a commercial-stage biotechnology company, develops antibody drug conjugates (ADC) for patients suffering from hematological malignancies and solid tumors. Its flagship product ZYNLONTA that is in Phase II clinical trial for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma;...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.